Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cerebrospinal fluid chitinase-3-like 2 and chitotriosidase are potential prognostic biomarkers in early multiple sclerosis.
Pycnogenol Attenuates the Release of Proinflammatory Cytokines and Expression of Perilipin 2 in Lipopolysaccharide-Stimulated Microglia in Part via Inhibition of NF-κB and AP-1 Activation.
Sleep disorders in multiple sclerosis and their relationship to fatigue.
Retinal ganglion cell layer thinning within one month of presentation for optic neuritis.
Incidence and prevalence of multiple sclerosis in the UK 1990-2010: a descriptive study in the General Practice Research Database.
Regnase-1 in microglia negatively regulates high mobility group box 1-mediated inflammation and neuronal injury.
A disturbed processing of graviceptive pathways may be involved in the pathophysiology of balance disorders in patients with multiple sclerosis.
Neuromyelitis optica-IgG testing in an Indian cohort with neuromyelitis optica and related demyelinating disorders: Our experience.
Web search behavior and information needs of people with multiple sclerosis: focus group study and analysis of online postings.
Perceptions of Participants in a Group, Community, Exercise Programme for People with Multiple Sclerosis.
A comparison of linear and nonlinear stability parameters in different clinical forms of multiple sclerosis.
Depressive state and chronic fatigue in multiple sclerosis and neuromyelitis optica.
Vitamin D: A Narrative Review Examining the Evidence for Ten Beliefs.
Progression on the Multiple Sclerosis Functional Composite in multiple sclerosis: what is the optimal cut-off for the three components?
Dimethyl fumarate attenuates intracerebroventricular streptozotocin-induced spatial memory impairment and hippocampal neurodegeneration in rats.
Gene expression in the spinal cord in female lewis rats with experimental autoimmune encephalomyelitis induced with myelin basic protein.
Developmental endothelial locus-1 is a homeostatic factor in the central nervous system limiting neuroinflammation and demyelination.
Immunomodulatory characteristics of mesenchymal stem cells and their role in the treatment of Multiple Sclerosis.
"History had taken such a large piece out of my life" - Neuroscientist refugees from Hamburg during National Socialism.
A role for Apolipoprotein A-I in the pathogenesis of multiple sclerosis.
Expression of Signaling Molecules in Progressive Multifocal Leukoencephalopathy.
Causes of death among persons with multiple sclerosis.
Third ventricular enlargement in early stages of multiple sclerosis is a predictor of motor and neuropsychological deficits: a cross-sectional study.
Spasticity treatment with onabotulinumtoxin A: data from a prospective German real-life patient registry.
Thalamo-striato-cortical determinants to fatigue in multiple sclerosis.
Pages
« first
‹ previous
…
597
598
599
600
601
602
603
604
605
…
next ›
last »